OLAXBT vs Mitosis — how do they compare? OLAXBT trades at Rp731.64 (market cap Rp168,03M, Rp15,61M 24h volume), while Mitosis trades at Rp454.11 (market cap Rp82,1M, Rp73,7M 24h volume). The key difference: OLAXBT is far larger — about 2× Mitosis's market cap, and OLAXBT's circulating supply is 230,3M / 1B AIO (24%) versus 181,3M / 1B MITO (19%) for Mitosis. Which is the better fit depends on your goals — on Pluang, investors hold OLAXBT for 3 Days and Mitosis for 20 Days on average.
| AIO | MITO | |
|---|---|---|
Market Cap | Rp168,03M | Rp82,1M |
Volume (24h) | Rp15,61M | Rp73,7M |
Circulating Supply | 230,3M / 1B AIO (24%) | 181,3M / 1B MITO (19%) |
Typical Hold Time | 3 Days | 20 Days |
What Pluang investors did over the last 30 days
OLAXBT is a decentralized AI trading platform that enables users to build and deploy automated trading agents through a modular, no-code infrastructure. Powered by its proprietary AIO Nexus Data Layer and Model Context Protocol (MCP), it supports real-time data access, standardized execution, and scalable agent interactions. The AIO token fuels payments, feature access, staking, and future governance within the ecosystem.
Read more on AIO →Mitosis is a cross-chain DeFi protocol that converts liquidity positions into programmable and composable assets. It tackles two significant inefficiencies in decentralized finance: the illiquidity of staked assets and limited access to high-yield opportunities for smaller users.
Read more on MITO →